Meet Our Clinical Team
Chief Executive Officer
Dr. Fishman founded Oncology Analytics (OA) in 2008. OA has grown rapidly, currently providing comprehensive oncology benefits management for members of health plans diagnosed with cancer. Through clinical research, patented technology and patient-focused customer services, OA ensures treating oncologists have the information they need to deliver the most efficacious, least toxic and most affordable chemotherapy treatments available to their patients.
Chief Medical Officer
Dr. Wilder graduated from the University of Maryland School of Medicine. He completed an internal medicine internship at the Greater Baltimore Medical Center, a radiation oncology residency at the University of Arizona, and an ASTRO research fellowship at the Stanford University Medical Center. He subsequently worked as a radiation oncology faculty member at UCSF, as well as the MD Anderson Cancer Center. Later, he obtained an MBA from Johns Hopkins University.
Dr. Bolger is a Medical Director of Oncology Analytics. He is board-certified in Medical Oncology and Internal Medicine. Dr. Bolger is a MD graduate of McGill University, Montreal, Canada. He completed his residency in Internal Medicine at The Johns Hopkins Hospital in Baltimore, MD, and a fellowship in Medical Oncology at Memorial Sloan-Kettering Cancer Center, New York, NY, and Fred Hutchinson Cancer Research Center, Seattle, WA.
Dr. De Masi received his medical degree from the University of Florence in Florence, Italy. He completed an internship at the University of Florence Hospitals in Florence, Italy and a radiation oncology residency at the Michael Reese Hospital Medical Center in Chicago, Illinois in 1987. In 1994 he founded the Atlantic Cancer Center in Berlin, Maryland to provide the surrounding community with high quality and comprehensive cancer treatment. In 2004 he returned to Chicago to serve as an Associate Clinical Professor and Medical Director/Chief of Services in the Department of Radiation Oncology at the University of Illinois.
Dr. Early is a Medical Director at Oncology Analytics. He practiced hematology/oncology in South Florida for 29 years in solo practice and in partnership. Dr. Early received his medical degree from Indiana University School of Medicine. His residency was at the University of South Florida and fellowship at the University of South Carolina. He is board-certified in Internal Medicine and Medical Oncology. Dr. Early is bilingual and speaks Spanish.
Dr. Kogler is a Medical Director at Oncology Analytics. He completed over five years of postgraduate training in medical oncology, including three years as a clinical and research fellow at Memorial Sloan Kettering Cancer Center. He is board-certified in Internal Medicine and Medical Oncology. He has practiced for 24 years in both the community and academic setting.
Medical Director, CMIO
Dr. Schorer focuses on clinical informatics and data management capabilities supporting our commitment to the delivery of safe, high-quality and cost-effective care for cancer patients. Prior to joining Oncology Analytics, Dr. Schorer was a clinician, educator and researcher in hematology and medical oncology at the Minneapolis VA Health Care System for more than two decades. In this position, she was a nationally known innovator in the design and optimization of electronic health systems and clinical decision support.
Dr. Schorer received her MD degree and did her Internal Medicine Residency at the University of Minnesota. She completed a Hematology/Medical Oncology Fellowship at the University of Washington and the University of Minnesota. She is board-certified in Hematology, Medical Oncology, and Clinical Informatics, in addition to holding a Certificate in Clinical Informatics from the American Medical Informatics Association.
Dr. Shimp is board certified in Internal Medicine and Medical Oncology. He has been in medical oncology practice for the past 30 years, at both Park Nicollet Medical Center in Minneapolis and at Affiliated Community Medical Centers in Willmar, Minnesota.
Director of Pharmaceutical Affairs
Dr. Bobolts is a Board Certified Oncology Pharmacist that serves as an oncology medical information resource for Oncology Analytics, responsible for providing recommendations for alternative therapy or support for existing anti-cancer treatment plans based on evidence-based medicine. She manages a team of oncology pharmacists, provides recommendations for oncology-related national drug policies, and performs population-based research.
She is a Clinical Affiliate Assistant Professor for Nova Southeastern University’s College of Pharmacy, lecturing on various topics such as oncology pharmacy therapeutics and pediatric leukemias, upon request. She developed an APPE (Advanced Pharmacy Practice Experience) at Oncology Analytics, to teach pharmacy students more about the practice of oncology pharmacy benefits management. She is published in Lancet Oncology, a peer reviewer for JAMA Oncology and Clinical Genitourinary Cancer, as well as an oncology pharmacy topic writer for www.idstewardship.com. Her main area of research interest is invasive breast cancer.
Clinical Oncology Pharmacist
Dr. Armitage is Board Certified Oncology Pharmacist with over nine years of clinical experience in oncology pharmacy which includes approximately five years at Moffitt Cancer Center. She is also an assistant professor in the Department of Pharmcotherapeutics and Clinical Research at the University of South Florida’s College of Pharmacy.
Clinical Oncology Pharmacist
Dr. Gavan is a Board Certified Oncology Pharmacist with over eight years of clinical experience in oncology with a special interest in hematology and hematopoietic stem cell transplantation. She has completed postgraduate ASHP-accredited residencies in pharmacy practice and oncology pharmacy. She has experience in various aspects of oncology pharmacy, including clinical practice, presentations at national and local meetings, and research.